错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Strahlentherapie des Mammakarzinoms – wann wieviel?

  • David Krug,
  • Nicolai Maass,
  • Marion van Mackelenbergh,
  • Jürgen Dunst

摘要

Background

Adjuvant radiotherapy is undergoing constant changes concerning the indications, treatment concepts and fractionation.

Objective

To give an overview over the current concepts and developments in adjuvant radiotherapy for patients with breast cancer.

Material and method

Semi-structured literature search.

Results

Adjuvant radiotherapy reduces the local recurrence rate even in patients with low-risk breast cancer. Recent studies investigate the exact subtype classification. Partial breast irradiation has become established as a standard treatment and an alternative for patients with low-risk breast cancer. The Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) meta-analysis supports the use of regional nodal irradiation while the National Surgical Adjuvant Breast and Bowel Project B‑51 (NSABP B‑51) suggests that de-escalation of locoregional radiotherapy may be possible for a subset of patients with stage ypN0. Moderate hypofractionation represents the gold standard and current study data also support its use in regional nodal irradiation and after implant reconstruction.

Conclusion

Modern adjuvant radiotherapy for patients with breast cancer is a personalized and individualized treatment.